Document Detail

Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
MedLine Citation:
PMID:  20629828     Owner:  NLM     Status:  MEDLINE    
Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) is reported to be an effective and safe treatment for superficial non-melanoma skin cancers. We have developed an photodynamic therapy with topical delta-aminolevulinic acid (ALA-PDT) protocol using intense pulsed light (IPL) for treating Bowen's disease (BD). Three patients diagnosed with BD by skin biopsy were recruited in this study. They received IPL treatment after 3 h of occlusive dressing with application of ALA. This protocol was repeated every 2 weeks for a total of five sessions. The treated areas did not show any signs of BD for more than 1 year; therefore, it appeared that the affected areas showed improvement in all the patients. No patients withdrew from the study because of side-effects. ALA-PDT with IPL as a light source is well tolerated by patients and is beneficial for treating BD.
Toshio Hasegawa; Yasushi Suga; Yuki Mizuno; Kunitaka Haruna; Hideoki Ogawa; Shigaku Ikeda
Related Documents :
7901248 - Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% ...
19691748 - Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of an...
20482238 - Treatment of refractory melasma with the medlite c6 q-switched nd:yag laser and alpha a...
19341628 - Analysis of histologic and clinical changes associated with polaris wr treatment of fac...
21784778 - Rituximab induces a rapid and sustained remission in colombian patients with severe and...
12049078 - Early treatment of an intruded primary tooth: a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of dermatology     Volume:  37     ISSN:  1346-8138     ISO Abbreviation:  J. Dermatol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-15     Completed Date:  2010-10-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600545     Medline TA:  J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  623-8     Citation Subset:  IM    
Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Aminolevulinic Acid / therapeutic use*
Bowen's Disease / drug therapy*,  pathology
Photochemotherapy / methods*
Photosensitizing Agents / therapeutic use*
Skin Neoplasms / drug therapy*,  pathology
Treatment Outcome
Reg. No./Substance:
0/Photosensitizing Agents; 106-60-5/Aminolevulinic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Community-based epidemiological study of psychosocial effects of acne in Japanese adolescents.
Next Document:  Interval sentinel lymph nodes in patients with cutaneous melanoma: A single-institution study in Jap...